Dr. Eloy Roman, MD

Dr. Roman practices at Eloy Roman MD PA in Miami Lakes, Florida.

Dr. Roman's NPI, 1811018765, was assigned on April 2, 2007. Dr. Roman holds Florida license ME 91124.

Dr. Roman's primary practice is Eloy Roman MD PA, at 5801 Nw 151st St, Miami Lakes, FL 33014-2437. The practice phone is (305) 828-1333.

Dr. Roman's primary practice is Eloy Roman MD PA in Miami Lakes, Florida.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Roman practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Roman's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Roman is board certified in hematology by the American Board of Internal Medicine. Dr. Roman is licensed in Florida.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer and lymphoma among the conditions Dr. Roman treats.

CMS data shows 111 Medicare services from Dr. Roman across 1 procedure code in 2024, all of them office visits, for 42 Medicare patients. Medicare paid $11,590 for them. Every service was in an office.

CMS counts 42 Medicare patients who saw Dr. Roman in 2024. The largest group is 65 to 74, with 16 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 71% are also on Medicaid. Their average risk score is 2.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Roman's median patient age at 78, with 60% women.

In 2024, Dr. Roman wrote 3,388 Medicare Part D claims for 567 patients. 72% of them were for generic drugs. CMS names the drug for 3,157 of them, across 50 drugs with 11 or more claims each, at $8,295,268 in total drug cost. In 2023, CMS named 3,194 claims across 53 drugs.

Dr. Roman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Roman, published from 2017 to 2022. The most frequent topics are Hemoglobins, Anemia, Iron-Deficiency and Disaccharides. Dr. Roman has published most often in Am J Hematol. Dr. Roman's most frequent co-authors are Michael Auerbach, MD, Richard J. Derman, MD and Robert A. Brodsky, MD.

Dmand AI links Dr. Roman to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Breast Neoplasms, Carcinoma, Non-Small-Cell Lung and Multiple Myeloma.

CMS Open Payments shows 2,352 general payments to Dr. Roman from 75 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 42% of the total. Alexion Pharmaceuticals, Inc. paid the most, $71,435.

Dr. Roman is in network with 10 carriers, including Aetna, United Healthcare and Molina. PPO plans come from the most carriers, 5. Check the plan with the practice before a visit.